Live Well Chiropractic & Rehab Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 420 W Wheatland Ave, Remus, MI 49340 Phone: 989-506-2231 |
Dr. Samantha Jo Beutler, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 420 W Wheatland Ave, Remus, MI 49340 Phone: 989-506-2231 |
News Archive
Enzon Pharmaceuticals, Inc. today announced that data from preclinical studies of three investigational messenger RNA (mRNA) antagonists based on the locked nucleic acid (LNA) technology platform have been accepted for poster presentation at the EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics, which is being held November 16-19 in Berlin, Germany.
Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).
Cancer survivor Jarod Finlay will share his experiences as the first patient to undergo an investigational procedure - stereotactic body radiation therapy - during a conference of world experts on the procedure this Friday and Saturday at the University of Rochester Medical Center.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
› Verified 1 days ago